arousal disorder

arousal disorder

Neurology
Any parasomnia disorder attributed to an abnormal arousal mechanism with frequent and/or prolonged stress not resolved by a flight-or-fight reaction or relaxation.
 
Classic arousal disorders
Sleepwalking, sleep terrors, confusional arousals.
 
Risk factors
Sleep apnoea, heartburn, periodic limb movement during sleep.
 
Complications
Injury, violence, excess eating, disturbance of bedpartner or family.
 
Management
Prescription drugs, behaviour modification (e.g., hypnosis or relaxation/mental imagery).

arousal disorder

Sleep disorders Any parasomnia disorder attributed to an abnormal arousal mechanism with frequent and/or prolonged stress Arousal disorders Sleepwalking, sleep terrors, confusional arousals Risk factors Sleep apnea, heartburn, or periodic limb movement during sleep Complications Injury, violence, excess eating, disturbance of bedpartner or family Management Prescription drugs, behavior modification–eg, hypnosis or relaxation/mental imagery. See Adaptation response, Fight-or-flight response. Cf Relaxation response.

a·rous·al dis·or·der

(ă-row'zăl dis-ōr'dĕr)
1. A broad term for parasomnia disorders that range from sleepwalking to sleep terrors; involves a state of being between sleep and wakefulness.
2. A condition or disorder in which normal sexual response is impaired or lacking (e.g., physiologic vaginal lubrication, maintenance of male erection).
References in periodicals archive ?
Dare Bioscience announced that it has met the funding requirement for obtaining an exclusive worldwide license to advance SST-6007, a potential treatment for Female Sexual Arousal Disorder, or FSAD.
M2 PHARMA-September 22, 2017-Innovus Partner Luminarie Receives New Zealand Approval for Zestra for Female Sexual Arousal Disorder as a Medical Device I
In DSM-5, (3) HSDD and female sexual arousal disorders are combined into a single entity, female sexual interest/arousal disorder (FSIAD), derived primarily from Basson's sexual response model, which suggests sexual response is not always a linear process, the distinction between desire and arousal may be artificial, and normal desire has a responsive component.
Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder.
The women had to score lower than 26 on the Female Sexual Function Index (FSFI) and lower than 11 on the Female Sexual Distress Scale (FSDS) and demonstrate one more of the following female sexual dysfunction (FSD) issues: hypoactive sexual desire disorder (HSDD), female sexual arousal disorder (FSAD), female orgasmic disorder (FOD), or combined genital and subjective arousal disorder.
When both groups are compared in terms of specific domains, the desire and arousal disorder rates were observed to be higher for patients with AGA.
Persistent genital arousal disorder in 18 Dutch women: Part II.
Female sexual arousal disorder (FASD) is the recurrent inability to attain sexual activity, or maintain it till completion, e.
The study included 50 women diagnosed with female sexual dysfunction, which included hypoactive sexual desire disorder, female sexual arousal disorder, female orgasmic disorder, or combined genital and subjective arousal disorder.
According to the study results, the most prevalent sexual dysfunctions among menopausal women were arousal disorder and dyspareunia.
It begins with a look at the description , prevalence, etiology, and biological factors of sexual dysfunctions including erectile disorder, female orgasmic disorder, delayed ejaculation, female arousal disorder and others.